| Date | Title | Description |
| 18.09.2025 | Nutrium Secures $12M Series A to Transform Corporate Nutrition Globally | Nutrium secured $12M in Series A funding. Vesalius Biocapital led the round. This capital fuels global expansion, targeting the US and Brazil. Nutrium delivers personalized corporate nutrition solutions. It addresses rising healthcare costs... |
| 17.09.2025 | Nutrium: $12 Million Series A Closed For Nutrition Solutions | Nutrium has closed a $12 million Series A financing round led by Vesalius Biocapital, with participation from Lince Capital, Indico Capital Partners, and Beta Capital. The funding arrives as the company’s all-in-one nutrition solution alrea... |
| 16.09.2025 | Nutrium capta US$ 12 milhões para expandir atuação no Brasil | A Nutrium, plataforma de acompanhamento nutricional personalizado para empresas, anunciou a captação de US$ 12 milhões em uma rodada Série A liderada pela Vesalius Biocapital, com participação da Lince Capital, da Indico Capital Partners e ... |
| 21.08.2024 | Caresyntax: $180 Million (Series C Extension And Growth Debt) Raised For Advancing Precision Surgery Platform | Caresyntax, a vendor-neutral precision surgery platform, announced it raised a total commitment of $180 million through a series C extension and growth debt expansion round. The investors in the $180 million round include Symbiotic Capital,... |
| 16.08.2024 | Caresyntax Secures $180 Million to Revolutionize Surgical Data Management | Caresyntax is on a mission. The startup has just raised $180 million to transform surgical data management. This funding comes as an extension of its Series C round, originally closed in 2021. The infusion consists of $80 million in equity ... |
| 15.08.2024 | Caresyntax scores $180M for its AI-enabled surgery platform | Photo: Morsa Images/Getty Images
Caresyntax, which provides an AI-enabled, data-assisted surgery platform for surgeons, secured $180 million in a Series C extension and growth debt-expansion round.
The $180 million comprises $80 million equ... |
| 28.07.2024 | CatalYm's $150 Million Bet on Cancer Resistance: A New Dawn in Immunotherapy | In the relentless battle against cancer, CatalYm has emerged as a beacon of hope. The Munich-based company recently secured $150 million in Series D funding, a significant leap forward in its mission to combat cancer therapy resistance. Thi... |
| 27.07.2024 | CatalYm: Cancer Therapy Resistance Mechanism Company Raises $150 Million In Series D | CatalYm announced the completion of a $150 million Series D financing. The oversubscribed funding round was led by new investors, Canaan Partners and Bioqube Ventures, and joined by Forbion’s Growth Opportunities Fund, Omega Funds and Gilde... |
| 02.11.2023 | Memo Therapeutics Raises CHF 25 Million Series C Financing | |
| 29.06.2023 | Vesalius Biocapital Holds First Close of Fourth Fund Raising EUR 95M | Vesalius Biocapital, a Luxembourg-based specialist life sciences venture capital investor, announced the first close of its fourth fund, Vesalius Biocapital IV, securing over €95m of commitments.
The fund received support from blue chip inv... |
| 02.03.2022 | Vesalius Therapeutics Raises $75M |
CAMBRIDGE,MA, Flagship Pioneering committed $75 million to Vesalius Therapeutics.
>> Click here for more funding data on Vesalius Therapeutics
>> To export Vesalius Therapeutics funding data to PDF and Excel, click here
F... |
| 16.02.2022 | Memo Therapeutics raises CHF 23 million | |
| 28.04.2021 | Caresyntax Raises $100M to Expand Digital Surgery Platform in Key Markets | What You Should Know:
– Caresyntax, a Boston-based enterprise-level digital surgery platform delivering actionable insights to make surgery smarter and safer, today announced that it has closed a significantly oversubscribed $100 million Se... |
| 25.06.2019 | Vesalius Biocapital III Closes €120M Life Sciences Focused Fund | Vesalius Biocapital III, the Strassen, Luxembourg-based specialist life sciences venture capital investor, closed the VBC III fund, securing €120m of equity commitments.
This includes commitments of €30 million from the European Investment ... |
| 25.06.2019 | Vesalius closes Fund III on €120m | Life science-focused Vesalius Biocapital Partners has raised €120m for the final close of its third venture capital fu |
| 18.05.2017 | Vesalius Biocapital Holds First Close of Third Venture Capital Fund, at over €65M | Vesalius Biocapital, a Luxembourg-based specialist life sciences venture capital firm, held the first close of its third fund, at over €65m.
Until the final closing in 2018, Vesalius Biocapital III will accept new investors on a “rolling cl... |
| 18.05.2017 | Term Sheet — Thursday, May 18 | DOING THEIR OWN THING
It’s fairly normal for successful venture capital pros to spend their careers building up a track record at a larger firm, and then “spin off” with their own firms. Lately, as limited partner interest in venture contin... |
| 02.10.2015 | Daily funding roundup - October 2, 2015 | Renovate America collected $90M; Dome9 Security raised $8.3M; Zeemee landed $5.8M
Propeller Aerobotics, a start-up that uses drones to make 3D maps for mining and construction companies has raised $1 million from investors including fund Bl... |
| 29.09.2015 | Daily funding roundup - September 29, 2015 | Trive Capital Management bagged $500M; Thumbtack raised $125M; Wheels Up raised $115M
The local services marketplace is filled with players, including companies like TaskRabbit, Angie's List and Yelp. Even companies like eBay, Amazon and Go... |
| 07.01.2015 | Genkyotex Raises CHF 20 Million and Considers IPO | |
| 25.10.2013 | Trod Medical Completes €4.75M Series B Financing | Trod Medical NV/SA, a Leuven, Belgium-based medical device company, completed a €4.75m Series B financing.
The round was co-led by Vesalius Biocapital (through its Vesalius Biocapital II Arkiv N.V. Fund) and Capricorn Venture Partners (thro... |
| 30.11.2012 | Euroscreen Completes €10M Series A Financing | Euroscreen SA, a Brussels, Belgium-based drug development company, has completed a €10m Series A financing.
The round was led by Vesalius Biocapital II Partners and SRIW (Société Régionale d’Investissement de Wallonie SA).
The company inten... |
| 30.04.2012 | Trinean Secures €2.7M | Trinean NV, a Gentbrugge, Belgium-based instrumentation company, has secured €2.7m of growth financing.
The round was led by the current investors Vesalius Biocapital, Capital-E, Baekeland II Fund and Fidimec.
The company intends to use the... |
| - | A successful start into the new year: New Growth Funding for MedTech Company Mecuris GmbH | German med-tech company Mecuris GmbH has successfully concluded a new funding round amounting to 3.6 million euros. In addition to the seed investors Bayern Kapital and High-Tech Gründerfonds (HTGF), the international investment company Mul... |
| - | Series-A Investment for Munich-based Medical Technology Startup Mecuris | Mecuris GmbH, a commercial-stage Munich-based medical technology startup focusing on the digitalization of prosthetics and orthotics, successfully completes its Series-A financing round of EUR 3.6m. In addition to existing seed investors Ba... |
| - | Flagship’s Vesalius launches with $75M to take AI into realm of common diseases | It’s no secret that drugs don’t work equally well for everyone. Doug Cole, chairman and co-founder of Vesalius Therapeutics, saw these limitations while he was a practicing physician in the 1990s. Even if a doctor diagnoses patients with th... |